Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2020-05-22 2020-05-21
Drug Identification Number 02357720 02357720
Brand name SEPTA-AMLODIPINE SEPTA-AMLODIPINE
Common or Proper name AMLODIPINE BESYLATE AMLODIPINE BESYLATE
Company Name SEPTA PHARMACEUTICALS INC SEPTA PHARMACEUTICALS INC
Ingredients AMLODIPINE AMLODIPINE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100s and 500s 100s and 500s
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-05-21 2020-05-21
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Supply issues Supply issues
Health Canada comments